We have continued feedback from regulatory surveyors regarding pain management and providing medication for the appropriate score.

Typically a handful of one-offs where the patient in one of the two areas:

We have continued feedback from regulatory surveyors regarding pain management and providing medication for the appropriate score.

Typically a handful of one-offs where the patient in one of the two areas:

We are a pediatric Epic(with First Data Bank) facility and currently working on reducing alarm fatigue in our systems. We have a suggestion before our committee currently to disable all Drug-Disease Warnings in the system. We have data showing that these warnings are bypassed 98.8% of the time and are looking into what happens the other 1.2% (same drug ordered later, or drug changed). One of the questions our committee got hung up on was whether or not other facilities utilize these warnings.

We recently implemented Alaris / Epic interop throughout our 8 hospital system. We're using Epic's daily compliance report to monitor compliance and identify & resolve issues.

Compliance with albumin administration via interop is almost zero. Nurses are administering via gravity because it takes hours to infuse with vented Alaris tubing due to the frequent alarms.

Do your sites allow pharmacists to be the independent double-check at the bedside to support nursing? We received this specific question for tenecteplase used in stroke alerts, but other meds have come up as well. Our primary concern is that administration is not in the pharmacist scope of practice for most medications. We also have concerns of a pharmacist cross-checking their own work. However, we recognize that the pharmacist is already at the bedside and very capable to support tenecteplase dosing. Thanks in advance.

We're working on a pharmacy specific active shooter prevention/training plan. Does anyone have one they would care to share? I'll share ours when completed.

Our current IV KCl policy states we can run KCl at 20 meq/hr on cardiac monitored patients with PERIPHERAL lines. There have been numerous error reports of RNs using two different peripheral sites to administer two different bags of 10 meg/100mL on cardiac monitors at the same time, which technically meets the max of 20 meq/hr. I think there is a lot of confusion on if this is appropriate or not. Does anyone spell this out in their policy if this is appropriate? Thanks in advance!

hello,

i am curious if other facilities have reported if equashield CSTD when connected with BBraun bags feels "looser". we have had 2 events of spillage and wondering if this is a noticed trend of a technique issue from our part. thank you

We are reviewing the double checks that are required for nurses for high risk medications. We were going to make a decision tree to establish a way to determine whether or not a independent double check by nursing.
Does anyone use anything like a decision tree that we could use ?

thanks !

Hello,

As many of you are likely aware, Akron pharmacetical's abrupt closure has put significant strain on the supply chain - particularly with eyedrops used for opthalmology procedures.

There is a growing body of literature from opthalmology organizations that support the use of multidose eye drops on multiple patients, provided that appropriately policies and procedures are in place to minimize risk of contamination to patients. Have any organizations acted on this and would be willing to share any guidance they have on how to approach this?